Immunotherapy

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read More

An engineering professor has received financial support from Susan G. Komen for breast cancer research. His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments. John… Read More

John Wilson, assistant professor of chemical and biomolecular engineering, earned an Alex's Lemonade Stand Foundation 'A' Award. (John Russell/Vanderbilt University) John Wilson, assistant professor of chemical and biomolecular engineering, recently was named an ‘A’ Award recipient by the Alex’s Lemonade Stand Foundation for developing a new class of therapeutic… Read More